載入...
Pharmacokinetics of alectinib and its metabolite M4 in a patient with advanced lung adenocarcinoma undergoing hemodialysis: A case report
Abstract This study presents the first detailed pharmacokinetic data of alectinib and its metabolite M4 in a patient with anaplastic lymphoma kinase (ALK)‐rearranged lung adenocarcinoma undergoing hemodialysis. When the patient was administered a daily 300 mg bid dose of alectinib, the maximal obser...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Wiley
2022-04-01
|
| 叢編: | Thoracic Cancer |
| 主題: | |
| 在線閱讀: | https://doi.org/10.1111/1759-7714.14357 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|